scRNA-seq analysis confirmed the presence of copy number variations (CNVs) and KRASG12D mutations in patient-specific tumour clusters and the absence of KRASG12D in KRAS wild-type LUADs (KW-LUADs) (Extended Data Fig. 1c). The gene discussed is KRAS; the disease is neoplasm.